By Maximilian Clarke
The government yesterday (Monday) set out a renewed strategy to protect the UK’s leading in the life sciences industry, announcing a £180m investment for medical breakthroughs.
The life sciences industry spans pharmaceuticals, medical technology, biotechnology and industrial biotechnology. The Government have launched its Life Sciences Strategy and a review of innovation in the NHS.
Commenting this morning, Britain’s leading business lobby, the Confederation of British Industry (CBI) welcomed the news, urging the NHS to adopt the investment across the service.
“It’s welcome news that the Government has set out a life sciences strategy demonstrating its commitment to work with businesses to develop this important part of our economy: the UK is a world leader in the life sciences industry and this new strategy will help us maintain our competitive advantage as the industry evolves and new models and ways of working emerge.
“The £180 million catalyst fund will help businesses accelerate the development of new treatments and technologies, turning our excellent research into commercial success.
“Increasing access to data will lead to greater innovation, help to improve outcomes for patients, and support growth. The challenge now is for the NHS and the industry to work together to make this plan a reality.”
Join us on